IL16 and neoplasm: Further analysis showed increased production of proinflammatory interleukins such as IL‐1β and IL‐16 and accumulation of various chemotactic agents, including CCL3, CCL4, CCL5, CXCL9, CXCL10, and CXCL11, in the tumor tissue [21].